NR4A1 and breast carcinoma: Analysis of the neoadjuvant trial JBCRG-07 indicated that metronomic cyclophosphamide plus letrozole increased the expression of the autophagy-related markers Beclin 1 and LC3 in hormonal receptor (HR)-positive breast cancer tissues 67.